Article
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement.
Transplantation - 15 Dec 2002
Macphee Iain A M, Fredericks Salim, Tai Tracy, Syrris Petros, Carter Nicholas D, Johnston Atholl, Goldberg Lawrence, Holt David W
Abstract excerpt
BACKGROUND: There is marked heterogeneity in blood concentrations of tacrolimus following standard body-weight-based dosing. This is most apparent in black patients, who have a higher dose requirement when compared with other ethnic groups. Differences in intestinal P-glycoprotein and hepatic and intestinal cytochrome P4503A activity have been postulated as contributing to this problem. METHODS: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
